Jubilant net up 106% in Sep quarterBS Reporter / New Delhi October 16, 2007Contract drug research and manufacturing firm Jubilant Organosys has registered 106% growth in net profit at Rs 110 crore for the quarter ended September 30, 2007, as against Rs 54.4 crore during the corresponding period the previous year.The net sales for the quarter grew 32.7% (year-on-year) from Rs 465.9 crore to Rs 618.3 crore. International revenues at Rs 326 crore increased 41.6% and contributed most to the business.The company attributed the growth to the substantially better operating performance and the revenues from its recently acquired injectable maker Hollister.Earnings Per Share (EPS) for the period rose to Rs 6.17 as against Rs 3.06 in the corresponding previous period.Shyam S Bhartia, CMD and Hari S Bhartia, co-chairman & MD, Jubilant said the results are proof of the strength of Jubilant
